Vanguard Group’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.91M | Buy |
4,755,327
+673,295
| +16% | +$411K | ﹤0.01% | 3395 |
|
|
2025
Q1 | $2.33M | Buy |
4,082,032
+809,988
| +25% | +$462K | ﹤0.01% | 3450 |
|
|
2024
Q4 | $4.68M | Buy |
3,272,044
+58,877
| +2% | +$84.2K | ﹤0.01% | 3298 |
|
|
2024
Q3 | $6.2M | Buy |
3,213,167
+48,901
| +2% | +$94.4K | ﹤0.01% | 3176 |
|
|
2024
Q2 | $9.81M | Buy |
3,164,266
+301,350
| +11% | +$934K | ﹤0.01% | 2939 |
|
|
2024
Q1 | $15M | Buy |
2,862,916
+403,472
| +16% | +$2.11M | ﹤0.01% | 2737 |
|
|
2023
Q4 | $7.97M | Buy |
2,459,444
+291,576
| +13% | +$945K | ﹤0.01% | 3075 |
|
|
2023
Q3 | $5.53M | Buy |
2,167,868
+168,489
| +8% | +$430K | ﹤0.01% | 3205 |
|
|
2023
Q2 | $11.7M | Buy |
1,999,379
+131,752
| +7% | +$773K | ﹤0.01% | 2851 |
|
|
2023
Q1 | $5.32M | Buy |
1,867,627
+251,411
| +16% | +$717K | ﹤0.01% | 3281 |
|
|
2022
Q4 | $3.25M | Buy |
1,616,216
+555,651
| +52% | +$1.12M | ﹤0.01% | 3484 |
|
|
2022
Q3 | $3.08M | Sell |
1,060,565
-2,971
| -0.3% | -$8.61K | ﹤0.01% | 3577 |
|
|
2022
Q2 | $5.99M | Sell |
1,063,536
-22,127
| -2% | -$125K | ﹤0.01% | 3277 |
|
|
2022
Q1 | $12.8M | Buy |
1,085,663
+528,845
| +95% | +$6.23M | ﹤0.01% | 3022 |
|
|
2021
Q4 | $10.6M | Buy |
556,818
+53,830
| +11% | +$1.02M | ﹤0.01% | 3172 |
|
|
2021
Q3 | $10.4M | Buy |
+502,988
| New | +$10.4M | ﹤0.01% | 3222 |
|